Physician
Rheumatology
Dr. Eliza F. Chakravarty, MD
|
|
Give Review
Eliza Chakravarty works in the field of Rheumatology. She studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care She has 2 awards "Fellow (FACR)" and "Fellow". Eliza Chakravarty is a published doctor and has 54 publications published. The lastest was: 'Which outcome measures in SLE clinical trials best reflect medical judgment?' Eliza F. Chakravarty accepts Medicare.
Publications
- Invariant natural killer T Cells in lupus patients promote IgG and IgG autoantibody production.
- Proceedings from the ACR Reproductive Health Summit: The management of fertility, pregnancy and lactation in women with autoImmune and systemic inflammatory diseases.
- Rheumatoid Arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.
- How should Lupus flares be measured? Deconstruction of the Safety of Estrogen in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity ...
- Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity.
- Excess Female Siblings and Male Fetal Loss in Families with Systemic Lupus Erythematosus.
- High Rate of Preterm Birth in Pregnancies Complicated by Rheumatoid Arthritis.
- Rheumatoid Arthritis and pregnancy: Beyond smaller and preterm babies.
- Treatment of Mild, Moderate, and Severe Lupus Erythematosus: Focus on New Therapies.
- Pregnancy outcomes after maternal exposure to rituximab.
- Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid Arthritis in Medicare managed care plans.
- Management of rheumatic Diseases during pregnancy.
- Obstetric outcomes in women with multiple Sclerosis and epilepsy.
- Viral infection and reactivation in autoImmune disease.
- Reduced disability and mortality among aging runners: a 21-year longitudinal study.
- What we talk about when we talk about contraception.
- Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle Cell disease.
- Prevalence of adult systemic Lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data.
- Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties.
- Successful use of rituximab for cutaneous Vasculitis.
- Science as experiment; science as observation.
- Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid Arthritis.
- Coronary artery disease in patients with systemic Lupus erythematosus.
- Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic Lupus erythematosus.
- Associations between rheumatoid Arthritis and malignancy.
- A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid Arthritis: a pilot study [ISRCTN03626626].
- Family planning and pregnancy issues for women with systemic inflammatory Diseases: patient and physician perspectives.
- Rheumatoid Arthritis and pregnancy: where do we go from here?
- Hospitalizations and mortality in Systemic sclerosis: results from the Nationwide Inpatient Sample.
- Rates and predictors of herpes zoster in patients with rheumatoid Arthritis and non-inflammatory musculoskeletal disorders.
- Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue Disease.
- Bleeding complications in patients on celecoxib and warfarin.
- Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus.
- Which outcome measures in SLE clinical trials best reflect medical judgment?
- Cardiac arrest due to succinylcholine-induced hyperkalemia in a patient with wound botulism.
- Rheumatic Syndromes associated with malignancy.
- The use of disease modifying antirheumatic drugs in women with rheumatoid Arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
- Skin cancer, rheumatoid Arthritis, and tumor necrosis factor inhibitors.
- A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse Systemic sclerosis.
- Improving patient reported outcomes using item Response theory and computerized adaptive testing.
- A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoArthritis of the hands.
- Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic Lupus erythematosus: results of a multicenter, phase Ib, double-blin...
- Long distance running and knee osteoArthritis. A prospective study.
- Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
- Arthritis: in the eye of the beholder?
- Risk of skin cancer in the drug treatment of rheumatoid Arthritis.
- Compression of morbidity 1980-2011: a focused review of paradigms and progress.
- Osteoporosis screening, prevention, and treatment in systemic Lupus erythematosus: application of the systemic Lupus erythematosus quality indicators.
- Vascular Complications of Systemic Sclerosis during Pregnancy.
- Development and initial validation of a self-assessed Lupus organ damage instrument.
- Immunosuppressive medications during pregnancy and lactation in women with autoImmune diseases.
- Contraceptive counseling and use among women with systemic Lupus erythematosus: A gap in health care quality?
- Vitamin d deficiency in a multiethnic healthy control cohort and altered Immune response in vitamin d deficient European-american healthy controls.
Schools
Johns Hopkins University School of Medicine
Santa Clara Valley Med Center
Stanford University Hospital
Stanford University
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
Conditions Treated
- Arthritis
- Classic Polyarteritis Nodosa
- Dermatomyositis
- Fibromyalgia
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
- Fellow
Education
-
Stanford University -
Santa Clara Valley Medical Center -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1396709663 | |
| NPPES Provider LastName | CHAKRAVARTY | |
| NPPES Provider FirstName | ELIZA | |
| NPPES Provider ZIPCode | 731044602 | |
| NPPES Provider State | OK | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 115.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396709663 |
| Last Name Of The Provider | CHAKRAVARTY |
| First Name Of The Provider | ELIZA |
| View All |
Similar Doctors
|
|
Dr. R H. Scofield, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William M. Schnitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan T. Merrill, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Natalya Z. Markoff, MD |
|
|
Dr. Judith A. James, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|